Orifarm gains OTC business through Takeda deal

24 April 2020 - Deborah Wilkes

Premium

Danish pharmaceutical company Orifarm is acquiring a portfolio of OTC and prescription pharmaceuticals sold in Europe from Japan’s Takeda in a deal worth up to approximately USD670 million.

Click tags below for more information on topics:

Orifarm Takeda

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: